CATHEPSINCYSTEINPROTEASEHEMMER

European patent · EP1902031 · Deleted

Register entry

Publication number
EP1902031
Application number
EP06752874
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 5, 2006
Published
Mar 26, 2008
Granted
Apr 11, 2012
Deleted
Jul 31, 2013
Reason
Annual fee unpaid
IPC classes
C07D 231/12 (2006.01)
A61K 31/415 (2006.01)
A61P 19/00 (2006.01)
A61P 19/02 (2006.01)
A61P 19/10 (2006.01)
Priority
US 696970 P 06.07.2005
PCT application
PCT/CA2006/001104 05.07.2006
PCT publication
WO2007/003056 11.01.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 19, 2014

    Deleted, fee unpaid

    Published in Swissreg on 19.02.2014

  2. Jun 26, 2012

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 26.06.2012

  3. Apr 11, 2012

    Granted

    Published in Swissreg on 11.04.2012

Parties

Holder

Merck Canada Inc.

16711 Trans-Canada Highway, Kirkland, QC H9H 3L1, CA

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

BLACK, Cameron

Kirkland, Québec H9H 3L1, CA

CRANE, Sheldon

Kirkland, Québec H9H 3L1, CA

OBALLA, Renata

Kirkland, Québec H9H 3L1, CA

ROBICHAUD, Joel

Kirkland, Québec H9H 3L1, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.